Cervical Gland Area as a Predictor of Success of Labour Induction
NCT ID: NCT04416022
Last Updated: 2020-06-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
100 participants
OBSERVATIONAL
2020-06-07
2022-06-07
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Transvaginal Ultrasound As Predictors of Successful Induction of Labour
NCT04477226
Comparison Between Ultrasonographic Cervical Length and Bishop Score in Preinduction Cervical Assessment
NCT01317706
Cervical Sliding Sign to Predict Outcome of Induction of Labor
NCT06324279
The Success of Labor Induction Based on a Modified BISHOP Score.
NCT04220320
Predicting the Outcomes of Labor Induction
NCT03175406
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Bishop score, cervical length, and the presence of cervical glandular area (CGA) will be documented for every patient up to 12 hours prior to the induction process.
The method of induction, data regarding patient demographics, the progress of labor, and the maternal and neonatal outcome will be documented following the delivery.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Ultrasound examination
Women that are planned for labour induction, will undergo a routine ultrasound examination prior to the initiation of the induction process.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Pregnancy 34-41 weeks of gestation
* Vertex presentation
* Induction methods (Oxytocin, prostaglandin 1 (PGE1), prostaglandin 2 (PGE2), double balloon catheter, rupture of memebrane (ROM)
Exclusion Criteria
* Contraindication to vaginal delivery
* Status post cervical cerclage
* Previous attempt of labor induction
* History of cervical surgery
* Active vaginal bleeding
18 Years
45 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Rambam Health Care Campus
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
SAAR AHARONI MD
Dr. Saar Aharoni
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
0711-19-RMB
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.